Loading
companiesCompany
Science 37 (eMed)
Pioneer of the 'metasite' decentralised trial model, acquired by eMed in 2024.
Overview
Science 37, based in Los Angeles and acquired by eMed in 2024, pioneered the metasite model of decentralised trials, in which a virtual site with its own investigators and nurses enrols patients wherever they live. Its oncology work has concentrated on symptom and supportive care trials, where remote conduct is most practical. OnCo links it to decentralised and hybrid clinical trials. Whether the virtual site model can extend from supportive care into treatment trials that require imaging and infusions is the open question. The decentralised trials page carries the wider evidence.
Similar pages
- CompanyMedable
Shares Decentralised and hybrid clinical trials and the tag supporting.
- CompanyMedidata (Dassault Systèmes)
Shares Trial modernisation roadmap: the randomised trial → platforms and adaptive designs → decentralised, pragmatic and always-on and the tag supporting.
- CompanyTriNetX
Shares Trial modernisation roadmap: the randomised trial → platforms and adaptive designs → decentralised, pragmatic and always-on and the tag supporting.
- TechnologyTelemedicine, teleoncology, and telepathology
Shares Decentralised and hybrid clinical trials, Trial modernisation roadmap: the randomised trial → platforms and adaptive designs → decentralised, pragmatic and always-on and the tag supporting.
- TechnologyElectronic patient-reported outcomes and remote monitoring
Shares Decentralised and hybrid clinical trials, Trial modernisation roadmap: the randomised trial → platforms and adaptive designs → decentralised, pragmatic and always-on and the tag supporting.
- TechnologyClinical trial software (EDC, eCOA, CTMS, RTSM)
Shares Decentralised and hybrid clinical trials and the tag supporting.
- TechnologyImaging core labs and central review
Shares Trial modernisation roadmap: the randomised trial → platforms and adaptive designs → decentralised, pragmatic and always-on and the tag supporting.
- CompanyFlatiron Health (Roche)
Shares Trial modernisation roadmap: the randomised trial → platforms and adaptive designs → decentralised, pragmatic and always-on and the tag supporting.